Submission Details
| 510(k) Number | K060564 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 03, 2006 |
| Decision Date | February 07, 2007 |
| Days to Decision | 341 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K060564 is an FDA 510(k) clearance for the INFINITI SYSTEM, a Test, Factor V Leiden Mutations, Genomic Dna Pcr (Class II — Special Controls, product code NPQ), submitted by AutoGenomics, Inc. (Carlsbad, US). The FDA issued a Cleared decision on February 7, 2007, 341 days after receiving the submission on March 3, 2006. This device falls under the Pathology review panel. Regulated under 21 CFR 864.7280.
| 510(k) Number | K060564 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 03, 2006 |
| Decision Date | February 07, 2007 |
| Days to Decision | 341 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | NPQ — Test, Factor V Leiden Mutations, Genomic Dna Pcr |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7280 |
| Definition | In Vitro Diagnostic Test To Detect The Factor V Leiden Mutation In Genomic Dna, As An Aid To Diagnosis In The Evaluation Of Patients With Suspected Thrombophilia. |